Skip to content
Back to Guavy Wire
Crypto

Bitcoin Fuels $32M Peptide Market Bypassing Banks

Instruments
BTC
Share

The peptide market has seen a significant surge in demand for experimental wellness compounds, with online sellers increasingly requiring Bitcoin (BTC) as payment. This trend is attracting first-time crypto users into an unregulated market that raises concerns about human safety and effectiveness.

According to Chainalysis, gray-market peptide vendors received $32 million in cryptocurrency during the first quarter of 2026, a 700% increase from the same period last year. With recent activity on pace to exceed $100 million annually, the sector is drawing attention from regulators and experts alike.

Many suppliers operate outside the prescription drug system, shipping compounds from overseas laboratories often labeled as research chemicals. Banks and card networks frequently reject these merchants due to legal and regulatory risks, leading some vendors to accept only cryptocurrency.

More on Crypto

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc